跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alfaren - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Alfaren
Approved
STANDARD
Alfaren
RPG Life Sciences Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cf10c4dd1446e72b
Company
RPG Life Sciences Ltd.
Type
Standard
Approval Details
Approval Id
cf10c4dd1446e72b
Drug Approval Philippines Name
Alfaren
Product Name
Alfaren
Registration Number
DRP-7884
Brand Name
Alfaren
Generic Name
Ketoanalogues + Essential Amino Acids
Dosage Form
Film-Coated Tablet
Dosage Strength
Combination
Manufacturer
RPG Life Sciences Ltd.
Importer
Biocare Lifesciences, Inc.
Distributor
UNILAB, Inc.
Company Detail Path
/organization/rpg-life-sciences-ltd
Issuance Date
06 March 2023
Expiry Date
12 September 2028
Pharmacologic Category
Renal Nutrition Therapy
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cf10c4dd1446e72b
Type
Standard
Back to Philippines FDA Approvals